India Ratings Upgrades Sai Life Sciences’ Long-Term Bank Facilities to IND AA
Sai Life Sciences Ltd · Others (Uncategorized) · 14 Nov 2026, 3:15 am
India Ratings Upgrades Sai Life Sciences’ Long-Term Bank Facilities to IND AA India Ratings upgraded Sai Life Sciences' long-term bank facilities rating to 'IND AA/Stable' from 'IND AA-/Positive' while affirming its short-term rating at 'IND A1+' across INR 7,690 million limits on 13th Nov'26. The upgrade reflects sustained CRO/CDMO growth, expanding commercial molecule pipelines, and improving financial metrics. Revenue reached INR 21,925 million in FY26 with a 29% EBITDA margin and interest coverage of 16.1x. A planned FY27 capex of INR 11-13 billion will temporarily constrain free cash flows and increase net leverage from 0.2x.
Original exchange filing (PDF)
More announcements from Sai Life Sciences Ltd
- Transcripts of Earnings call organized on 06th November 2026 · 12 Nov 2026
- Monitoring Agency Report for the Quarter ended 30th September 2026 · 12 Nov 2026
- Audio Recording of Earnings call for Q-2 FY 2026-27 · 06 Nov 2026
- Investor Presentation on Q-2 FY 2026-27 Financial Results · 06 Nov 2026
- Press Release on Unaudited Financial Results for the Second Quarter and Half Year Ended 30th September 2026. · 06 Nov 2026
- Allotment of 1,08,005 Equity having Face Value of Rs.1/- against the options exercised in accordance with the Companies ESOP Plans · 06 Nov 2026
- Sai Life Sciences Limited has informed the Exchange regarding Allotment of 108005 Shares. · 06 Nov 2026
- Change In Management - Appointment of SMPs · 06 Nov 2026
